"Designing Growth Strategies is in our DNA"
In February 2019, FDA approved the use of Yupelri inhalation solution manufactured by Mylan for patients suffering from chronic obstructive pulmonary disease. According t... Read More
Region : Global | Published Date: Upcoming | Report ID: FBI101176 | Status : Upcoming